Abstract
The Bartonella genus of bacteria encompasses ubiquitous species, some of which are pathogenic in humans and animals. Bartonella henselae, the causative agent of Cat Scratch disease, is responsible for a large portion of human Bartonella infections. These bacteria can grow outside of cells, replicate in erythrocytes and invade endothelial and monocytic cells. We have previously reported reduced antibiotic susceptibility of intracellular Bartonella. In this study we performed comparative transcriptomic analyses between the extracellular and intracellular B. henselae phenotypes. Overall, specific genes involved in invasion, virulence, extracellular adhesion of type 4 secretion system were downregulated following intracellular invasion of B. henselae. Downregulation included BadA, a well-characterized adhesin molecule, of critical importance for cell invasion. These studies demonstrate the ability to purify Bartonella RNA from infected cells and offer a repository of gene expression data for future research. The development of novel therapeutics will benefit from the ability to determine target expression by Bartonella in relevant microenvironments.
Subject terms: Transcriptomics, Molecular biology
Transcriptomic analysis of Bartonella henselae, differentiating between the extracellular (planktonic) and intracellular environment. Changes in gene expression reflect virulence, invasion and adhesion for extracellular matrices.
Introduction
Bartonella henselae is a gram-negative zoonotic and facultative intracellular bacterium, which infects numerous animal species, including humans and cats; 30–60% of domestic or feral cats in the U.S. are infected with B. henselae. Transmission among cats is mediated by the cat flea, Ctenocephalides felis, and to humans by cat scratches or cat bites1,2. As the primary reservoir host, chronic, relapsing bacteremia occurs in cats, most often without clinical signs of disease. Infection of immunocompetent individuals with B. henselae results in cat scratch disease (CSD), which is a usually a self‐limiting infection3. In contrast, immunosuppressed and immunocompetent individuals infected with B. henselae can develop systemic infections accompanied by diverse pathologies involving the cardiovascular, musculoskeletal and nervous systems4–14.
B. henselae has the capacity to survive in murine macrophages, and dog and human endothelial cells by inhibition of phagosome fusion with lysosomes, where the bacteria replicate within these cells15–18. As facultative intracellular pathogens, the proposed pathogenesis involves initial infection of endothelial cells, after which Bartonella infects a subpopulation of erythrocytes19,20. Adhesion to endothelial cells by B. henselae has mainly been studied in human umbilical vein endothelial cells, which has provided an in vitro system to study the basis of angioproliferation21. B. henselae expresses surface adhesins, including BadA22, which is essential for the attachment to host extracellular matrix (ECM) proteins including collagen, laminin, and fibronectin, with fibronectin of particular importance for bacterial adhesion23,24. The interaction with fibronectin occurs at repetitive motifs in the BadA neck/stalk region25 that helps the bacteria to adhere to host cells. A recent study has evaluated the role of fibronectin as a mediator in bacterial cell-host adhesion, where the fibronectin knockout diminished Bartonella adherence to the endothelial cells26, documenting a pivotal role of this ECM protein for bacterial adhesion. Bartonella, once attached, is known to be internalized by conventional phagocytosis and by an invasome-mediated internalization mechanism in endothelial cells17,27. Generally, bacterial internalization leads to apoptosis of the host cell. However, Bartonella evolved the anti-apoptotic effect21 that is mediated by the pathogen’s BepA protein that activates human adenylyl cyclase 7 to elevate cAMP levels28,29, resulting in enhanced bacterial survival within host cells. Colonization of endothelial cells is important in both reservoir and incidental mammalian hosts and is considered essential for the establishment and maintenance of the angioproliferative lesions reported in cats, dogs, humans and other animals1,21,30.
A case report from 1985 showed the presence of gram-negative bacilli, presumed to be B. henselae, as clumps in vessel walls, observed both intracellularly and free in necrotic debris in a patient with CSD31. These observations of bacteria located near or adjacent to the cell nuclei were made using staining techniques, such as Warthin-Starry silver stain, which are not species-specific. In another case report of five patients, histopathologic findings demonstrated the presence of bacteria extracellularly and inside macrophages of skin biopsy specimen32. Similarly, these bacteria were found both extracellularly and intracellular in areas of necrosis in lymph node. Later, another study identified the presence of extracellular bacteria only, forming small groups in necrotic and viable regions of lymph node biopsies from two different patients33. An ultrastructural analysis of the lymph node of a CSD patient with AIDS demonstrated the presence of clusters of small, pleomorphic bacteria in degenerated extracellular collagenous tissue of the lymph node as well as in the walls of blood vessels34. A few bacteria were also observed in phagosomes of macrophages. More recently, B. henselae was detected in a melanoma biopsy tissue specimen, where the bacteria appeared to be intracellular5. These observations collectively support B. henselae’s dual lifestyle in human infections. This adaptability likely enhances the pathogen’s survival by allowing it to employ different virulence strategies based on its location. For instance, intracellular B. henselae in melanoma cells increased expression of VEGF and interleukin-8, potentially promoting angiogenesis5. This ability to exist both intracellularly and extracellularly may contribute to the diverse clinical manifestations of Bartonella infections and its capacity to evade host immune responses35.
Historically, to identify functional interactions of the transcriptional regulatory systems and to perform quantitative gene expression analyses, quantitative PCR (qPCR) was utilized. Using qPCR, researchers determined that the expression of the rpoE gene was upregulated when B. quintana was exposed to the body louse (28 °C) versus the human host (37 °C) temperature36. Subsequently, a custom microarray platform was utilized to study and analyze temperature-specific and growth phase-specific transcriptomics of B. quintana at host and vector body temperatures37. A cluster of growth-specific genes were found, and it was determined that B. quintana has unique transcriptional profiles when grown in vitro on agar at human host (37 °C) temperature compared with arthropod vector (28 °C) temperature37. Microarray has also been utilized to study the gene expression of B. henselae during infection of human endothelial cells38. Microarray technology was the first to document that BatR is a protein directly involved in the regulation of genes encoding the VirB Type IV secretion systems (T4SS)and the Bartonella effector proteins (Beps) that are associated with Bartonella pathogenicity38. As RNA sequencing (RNA-seq) was developed and became more readily available, it was used to further study the importance of gene expression and regulation in Bartonella. RNA-seq has revealed nine novel, highly-expressed intergenic transcripts of B. henselae that belong to the Brt family of RNAs3. The identification of these genes has further enhanced our knowledge of their role in expression of a major virulence factor gene (badA) and the pathogenesis of B. henselae infections3.
Intracellular bacterial infections are often studied using cell lines as host models39,40. DH82 cells are a canine macrophage cell line that was isolated from a 10-year old dog with histiocytic sarcoma41. This cell line is been applied as a useful in vitro tool for the investigation of canine macrophages in a wide range of scientific fields, including veterinary oncology and infectious diseases42. In the field of infection research, DH82 cells are capable of being infected with several bacterial species, including Rickettsia43, Ehrlichia (sp. HF, a model bacterium to study fatal human Ehrlichiosis)44, Brucella canis45, and Leishmania infantum46. Investigators have also used these cells to isolate and characterize novel, pathogenic, obligate intracellular strains of Ehrlichia minasensis47 and Rickettsia tillamookensis43. The DH82 cell line was also used as a model in the discovery of two Ehrlichia virulence genes that are responsible for host infection48. Since this cell line is considered permissive for Bartonella, previous studies have utilized these cells in Bartonella serological testing using immunofluorescence49–51 and in testing and determination of effective drug combinations that could potentially be used to treat bartonelloses52.
Similar to B. quintana and the human body louse, B. henselae adapts to very diverse environments, such as the cat flea vector where the temperature is low and the vertebrate host, where temperature is higher. Very little is known about how B. henselae modifies gene expression profiles to efficiently transition from the conditions of the cat flea vector to the mammalian host3. As mentioned above, a few reports have proposed a role for several different regulatory proteins in host adaptation by B. henselae and B. quintana37,38,53,54. B. henselae can exist in both intracellular and extracellular forms during its infection cycle. These bacteria are found extracellularly, especially during initial stages of infection and transmission. BadA is used to attach the bacterium to host cells and ECM proteins55. Then, the bacteria can stimulate angiogenesis through secreted factors like BafA, which interacts with host VEGF receptors56. After the entry into the host cells, the bacteria use the VirB/VirD T4SS for survival, injecting effector proteins into host cells55,57. Inside the cells, B. henselae can form aggregates within structures called invasomes17,56. This ability of transition between extracellular and intracellular states helps Bartonella adapt to different host environments and evade immune responses. In this study, we used RNA-seq analysis to compare gene expression of B. henselae within DH82 cells to expression by the free-living bacteria. The compiled transcriptome of this pathogen provides a novel and essential contribution to the study of Bartonella infections and clinical interventions.
Results
Differentiation of invasive bacteria from surface-adhered bacteria
Cells were infected with different B. henselae multiplicities of infection (MOI), as described in our previous study52. An MOI of 1:100, where the highest percentage (100%) of DH82 cells were infected with Bartonella, was used in this study. To differentiate intracellular bacteria from the surface-adhered bacteria, we used MemBrite Fix staining to stain the host cell membrane, along with Bartonella-specific antibody to stain for the bacteria. Initially, DH82 cells were stained with either DAPI alone or in combination with MemBrite Fix staining to determine if the dye would stain the canine cell cytoplasm (Supplementary Fig. 1A, B). To determine the specificity of the secondary antibody, a secondary antibody alone control (Supplementary Fig. 1C) was included. Permeabilization was the only additional step that was added for staining intracellular bacteria. Permeabilization caused the internalization of the anti-Bartonella antibody into the cell, which distinguished intracellular bacteria from the bacteria attached to the cell surfaces. Comparison of fixed/non-permeabilized cells stained for Bartonella to the cells where permeabilization was employed clearly documented the intracellular localization of the bacteria (Fig. 1A, B; Supplementary Fig. 2). Confocal microscopy generated an image of the intracellular bacteria (Fig. 1C).
Fig. 1. Infection of DH82 cells with Bartonella henselae.
Indirect immunofluorescence images showing staining of Bartonella henselae in Panels A & B. The staining in Panel B was differentiated from Panel A by including an extra permeabilization step. Bacteria were processed for immunofluorescence assay using rabbit anti-Bartonella antibody and consequently stained using secondary antibody Goat Anti-rabbit IgG-Alexa Fluor 594 (red) and MemBrite Fix stain was used to stain the DH82 cell membrane (Green). The extracellular bacteria stained in red colocalized with the cell membrane stained in green. C A confocal image showing the intracellular bacteria in three dimensions. D The viable intracellular bacteria was stained using RNAscope.
A subsequent set of experiments was conducted to quantify the fraction of extracellular versus intracellular bacteria. Immunofluorescent staining was repeated, using different fluorescently-tagged antibodies before and after permeabilization. The counts from the individual fields were shown Table S1 and the representative images are shown in Supplementary Fig. 3. A total of at least 50 images were taken from each individual experiment and yellow dots (extracellular bacteria) were counted manually from each field. A total of four individual experiments were performed to finalize the average extracellular bacteria percentage, which was 12.795%
RNAscope technique to determine bacterial RNA viability
To optimize the protocol and to test the viability of the bacteria inside of DH82 host cells, a positive control RNA probe was used alongside a negative control probe. Supplementary Fig. 4 panel illustrates RNAscope staining of the positive control (PPIB), which is considered a standard to determine the RNA quality of the cells and the negative control probe targeting the dapB gene of Bacillus subtilis. To validate the presence of viable B. henselae inside the cells, we used an RNA probe targeting the B. henselae 23s ribosomal RNA gene (Fig. 1D).
RNA integrity check and enrichment of bacterial RNA
Using the osmotic lysis method, we were able to isolate 5 × 105 ± 2.05 bacteria from the infected DH82 cells. After lysing the bacteria, RNA integrity was assessed using a Bioanalyzer (Agilent) and their nano chip (Fig. 2A). Electrophoretic analysis revealed strong bands corresponding to the 18S and 28S ribosomal RNA (rRNA) of the DH82 host cells, with faint bacterial RNA bands corresponding to the 16S and 23S rRNA in samples, which confirmed the predominance of eukaryotic ribosomal RNA in the samples and suggested that the host mRNA would probably substantially predominate over bacterial transcripts. To eliminate host RNA from the samples for bacterial transcriptomic analyses, the MICROBEnrich™ kit was used, which selectively removes 18S, 28S rRNA, and polyadenylated mRNA. To our knowledge, this is the first time this kit was tested on a Canine species cell line for the removal of RNA. Following MICROBEnrich™ treatment, electrophoretic analysis of the total RNA obtained with this method revealed the presence of bands corresponding to the 16S and 23S bacterial rRNA, whereas the host 28S and 18S rRNA were not detected. Since the MICROBEnrich™ kit doesn’t remove 5S and 5.5S rRNA, these bands were clearly seen in the enriched samples (Fig. 2A). Enriched samples 6, 7, and 8 from Fig. 2A were used as intracellular/experimental (inside DH82 cells) samples. Samples labeled controls 1, 2 and 4 from Fig. 2B were used as control samples (planktonic bacteria). The RNA integrity number of the control and the experimental samples before enrichment is listed in Fig. 2C. Since bacteria-enriched samples were run on the same chip as the pre-enriched samples, a RIN value was not generated for the enriched samples, possibly because of corresponding 5 and 5.5S bands from host cells.
Fig. 2. Evaluation of the RNA extracted from planktonic and intracellular bacteria.
A Image of the bioanalyzer gel for three independent RNA samples that were extracted from the DH82 cells that were infected with B. henselae. Sample 1 represents the RNA from the DH82 cells alone. Samples 2, 3, and 4 represent the RNA isolated from DH82 cells infected with B. henselae before enriching the sample for bacterial RNA. Sample 5 represents the RNA from B. henselae alone and samples 6, 7, and 8 represent the RNA after enrichment for bacteria. L, ladder. The 28S and 18S (host) rRNA bands, 23S and 16S (bacteria) rRNA bands are indicated by the black arrows. Before enrichment, faint bacterial rRNA bands can be visualized in samples 2, 3, and 4. After enrichment, 5 and 5.5S rRNA bands can be visualized in samples 6, 7, and 8. B Image of the bioanalyzer gel for three independent RNA samples that were extracted from B. henselae. Control 1, Control 2, and Control 4 represent the RNA from the B. henselae. C Table showing the RNA integrity values of the samples. In this manuscript, Control 1, 2 and 4 were used as planktonic samples and samples 6, 7, and 8 were used as experimental (intracellular) samples.
RNA-seq analysis of B. henselae isolated from DH82 cells
Using Lexogen RiboCop rRNA Depletion kits for DH82 cells and bacteria simultaneously, rRNA was removed from the in vitro grown bacteria directly and from enriched intracellular bacterial RNA. Libraries were generated, and Illumina sequencing was performed on RNA samples from B. henselae grown blood agar plates and in the enriched, intracellular bacteria (inside DH82 cells). Fig. 3 depicts the RNAseq pipeline for steps in the analysis process. Since a well-annotated genome of B. henselae San Antonio 2 strain is not available, we used B. henselae Houston-1 strain genome as the nearest annotated neighboring genome. The planktonic bacteria samples resulted in mapping more than 70–73% of the reads after processing for low-quality reads (Table 1). However, only 4–6% of the reads were mapped from the intracellular bacteria samples to the bacterial reference genome, suggesting that the rest of the reads were host RNA. Reads mapped to 99.57% of the genes on the B. henselae Houston-1 reference genome, giving sufficient data to describe the transcriptome. Only 7 genes out of 1665 had no read counts. However, due to large differences in the total number of mapped reads between planktonic and intracellular bacteria samples (Tables S2 and S3), we downsampled the in vitro reads (Table 1). This involved selecting a subset of data from the larger dataset to reduce the chances of overestimation errors generated by comparison of large to small number reads. We performed two rounds of downsampling, initially by reducing the total number of reads to 4.5 million and subsequently to 3 million reads. Downsampling the reads to 4.5 million generated more total number of reads from controls after processing, compared to the experimental samples, than we anticipated (Table S4). This served as the rationale behind doing another round of down sampling to 3 million reads from the original reads. After this processing, this second round resulted in a similar total number of reads among all the samples (Tables 2 and S4), which allowed for a more appropriate analysis with less saturation effects due to the excess data depth of the in vitro
Fig. 3. An overview of the RNA-sequencing pipeline.
This figure was created with BioRender.com.
Table 1.
Total number of reads that were generated per sample
| Samplea | Number of input reads | Mapped reads | Mapped reads % | Reads left after UMI deduplication |
|---|---|---|---|---|
| C1 | 61,366,102 | 45,305,773 | 69.41 | 38,152,844 |
| C2 | 71,867,118 | 52,676,704 | 71.35 | 43,622,424 |
| C3 | 62,836,096 | 47,755,209 | 73.98 | 40,008,051 |
| E1 | 57,392,557 | 4,081,782 | 5.84 | 2,615,517 |
| E2 | 61,250,989 | 3,465,895 | 4.59 | 2,011,867 |
| E3 | 63,862,636 | 3,937,077 | 5.11 | 2,502,664 |
Values in bold highlight the effect of down-sampling
aSamples C1, C2, and C3 represent the in vitro (planktonic) bacteria and samples E1, E2, and E3 represent intracellular bacteria
Table 2.
Reads from control samples were downsampled to 3 million to generate similar number of reads across all the samples
| Sample | Number of input reads | Mapped reads | Mapped reads % | Reads left after UMI deduplication |
|---|---|---|---|---|
| C1 | 3,000,000 | 2,226,020 | 74.77% | 2,104,650 |
| C2 | 3,000,000 | 2,208,581 | 74.23% | 2,091,311 |
| C3 | 3,000,000 | 2,294,677 | 77.12% | 2,166,946 |
| E1 | 57,392,557 | 4,082,878 | 7.18% | 2,362,193 |
| E2 | 61,250,989 | 3,478,325 | 5.74% | 1,799,680 |
| E3 | 63,862,636 | 3,941,004 | 6.23% | 2,288,239 |
Values in bold highlight the effect of down-sampling
Gene expression of intracellular bacteria
We have included the B. henselae gene expression data from the use of 4.5 million reads and 3 million reads (Tables S5 and S7) and raw total counts from 3 million reads (Table S6). Even after rRNA depletion, we observed reads mapping to the rRNA. Prior to normalizing the counts, rRNA counts and genes that had zero read counts were removed and then were normalized. The results from the counts that didn’t contain rRNA were documented (Table S8 and the genes that were excluded from the analysis were added to the Table S9). We observed that the changes in the expression levels of 289 genes were changed ≥1.5-fold and 114 genes had log2fold change of ≥2-fold and were significantly (p < 0.05) increased or decreased when planktonic and intracellular growth conditions were compared. Overall, 70 genes were repressed, and 44 genes were activated with two or more-fold change (Fig. 4A). We have listed the top 20 up- and downregulated genes in Table 3 along with their normalized counts. A heatmap was generated using the Z-scores and presented as Fig. 4C. Based upon principal component analysis (PCA), the variation between the growth conditions (planktonic vs intracellular) was ~80% whereas, within the samples there was a variance of 12.4% (Fig. 4B). A total of 1652 gene normalized counts were used to generate the PCA plot (Table S10).
Fig. 4. Total number of genes that were differentially expressed between planktonic and intracellular conditions of B. henselae.
A Total number of genes that were statistically upregulated or downregulated in a comparison between B. henselae grown on a blood agar plate (planktonic) to B. henselae grown inside DH82 cells. B A PCA plot that was generated using ClustVis is shown. Normalized read counts from all the genes were used. The values were ln(x)-transformed and Pareto scaling is applied to rows and Nipals PCA was used to calculate principal components. The X and Y axes show principal component 1 and principal component 2 that explain 79.9% and 12.4% of the total variance, respectively; N = 6 data points. C Heatmap showing the Top 20 up and top 20 down genes that changed their gene expression significantly. Here we used Z-score of the normalized counts to generate a heatmap. ChatGPT 3.5 was used to write a script for generating this heatmap.
Table 3.
The top 20 upregulated genes and top 20 downregulated genes in the intracellular B. henselae along with their normalized counts
| Top 20 upregulated genes in the intracellular bacteria | Normalized counts | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | gene name | baseMean | log2FoldChange | PValue | PAdj | FDR | C1dedup | C2dedup | C3dedup | E1dedup | E2dedup | E3dedup |
| CAF27495-1 | hypothetical genomic island protein | 6943.3 | 6.9 | 0.00E + 00 | 0.00E + 00 | 0 | 55 | 64 | 50 | 6941 | 6498 | 7222 |
| CAF27497-1 | hypothetical genomic island protein | 2864 | 5.7 | 0.00E + 00 | 0.00E + 00 | 0 | 54 | 55 | 52 | 2896 | 2627 | 2908 |
| CAF27494-1 | hypothetical protein | 583.3 | 5.6 | 8.70E–166 | 0.00E + 00 | 0 | 19 | 8 | 9 | 559 | 568 | 587 |
| CAF27498-1 | hypothetical protein | 352.3 | 5 | 4.10E–77 | 0.00E + 00 | 0 | 16 | 10 | 6 | 345 | 299 | 381 |
| BH08960-1 | tRNA-Asp | 532 | 4.9 | 1.40E–94 | 0.00E + 00 | 0 | 21 | 19 | 12 | 548 | 600 | 396 |
| BH12460-1 | tRNA-Leu | 223.3 | 4.3 | 3.10E–40 | 0.00E + 00 | 0 | 12 | 13 | 6 | 189 | 257 | 193 |
| CAF28127-1 | Chaperonin protein groES | 8312 | 4.1 | 0.00E + 00 | 0.00E + 00 | 0 | 432 | 469 | 504 | 7935 | 7465 | 8131 |
| CAF28204-1 | hypothetical protein | 10541.7 | 4 | 2.70E–237 | 0.00E + 00 | 0 | 587 | 639 | 651 | 9681 | 11588 | 8479 |
| CAF28332-1 | trwH1 (hypothetical protein) | 235 | 3.9 | 3.30E–35 | 0.00E + 00 | 0 | 23 | 13 | 10 | 247 | 187 | 225 |
| BH12490-1 | tRNA-Ser | 254.7 | 3.9 | 5.80E–34 | 0.00E + 00 | 0 | 21 | 10 | 17 | 249 | 294 | 173 |
| BH01420-1 | tRNA-Ser | 298.7 | 3.6 | 6.70E–44 | 0.00E + 00 | 0 | 31 | 19 | 17 | 302 | 291 | 236 |
| CAF28335-1 | trwH2 (hypothetical protein) | 92.7 | 3.2 | 9.90E–19 | 0.00E + 00 | 0 | 8 | 9 | 10 | 79 | 72 | 100 |
| CAF28048-1 | hypothetical protein | 787 | 3.1 | 1.30E–95 | 0.00E + 00 | 0 | 102 | 71 | 75 | 639 | 740 | 734 |
| BH01340-1 | tRNA-Arg | 186.7 | 3.1 | 2.20E–22 | 0.00E + 00 | 0 | 28 | 15 | 16 | 178 | 185 | 138 |
| CAF27493-1 | Anti-repressor protein | 285.7 | 3.1 | 1.10E–20 | 0.00E + 00 | 0 | 49 | 29 | 13 | 240 | 257 | 269 |
| BH09590-1 | Prophage integrase | 58.3 | 3.1 | 1.40E–14 | 0.00E + 00 | 0 | 6 | 7 | 5 | 49 | 53 | 55 |
| BH09190-1 | tRNA-Ser | 74.7 | 2.9 | 1.20E–11 | 0.00E + 00 | 0 | 10 | 9 | 7 | 56 | 97 | 45 |
| CAF27177-1 | hypothetical prophage protein | 973 | 2.8 | 1.90E-107 | 0.00E + 00 | 0 | 129 | 145 | 102 | 859 | 849 | 835 |
| CAF27180-1 | hypothetical prophage protein | 65.3 | 2.7 | 3.20E–11 | 0.00E + 00 | 0 | 9 | 10 | 6 | 46 | 76 | 49 |
| CAF28126-1 | Chaperonin protein groEL | 19433 | 2.5 | 3.50E–209 | 0.00E + 00 | 0 | 2918 | 2755 | 2879 | 16833 | 15536 | 17378 |
| Top 20 downregulated genes in the intracellular bacteria | Normalized counts | |||||||||||
| ID | gene name | baseMean | log2FoldChange | PValue | PAdj | FDR | C1dedup | C2dedup | C3dedup | E1dedup | E2dedup | E3dedup |
| CAF27413-1 | 50S ribosomal protein l7 /l12 (rplL) | 851.7 | –3.5 | 4.40E–109 | 0.00E + 00 | 0 | 735 | 863 | 744 | 90 | 69 | 54 |
| CAF28057-1 | Glycine cleavage system protein h (gcvH) | 616.3 | –3.3 | 3.80E–98 | 0.00E + 00 | 0 | 558 | 586 | 539 | 69 | 51 | 46 |
| CAF27262-1 | Adenine DNA methyltransferase protein (ccrM) | 1754.7 | –3.1 | 9.20E–150 | 0.00E + 00 | 0 | 1560 | 1573 | 1592 | 222 | 140 | 177 |
| CAF27005-1 | nrdI protein (nrdI) | 1685.7 | –3 | 4.80E–149 | 0.00E + 00 | 0 | 1565 | 1543 | 1407 | 220 | 158 | 164 |
| CAF27826-1 | 50S ribosomal protein l18 (rplR) | 1145.7 | –3 | 3.00E–145 | 0.00E + 00 | 0 | 977 | 1078 | 990 | 144 | 132 | 116 |
| CAF27004-1 | Glutaredoxin-like protein nrdH (nrdH) | 599.3 | –3 | 9.40E–77 | 0.00E + 00 | 0 | 469 | 568 | 565 | 64 | 66 | 66 |
| CAF28170-1 | hypothetical protein | 327 | –3 | 4.40E–43 | 0.00E + 00 | 0 | 309 | 250 | 314 | 34 | 40 | 34 |
| CAF28362-1 | SUN protein (FMU protein) (sun2) | 6607 | –2.9 | 1.70E–171 | 0.00E + 00 | 0 | 5592 | 5721 | 6121 | 918 | 703 | 766 |
| CAF27412-1 | 50S ribosomal protein l10 (rplJ) | 1646 | –2.9 | 7.40E–164 | 0.00E + 00 | 0 | 1366 | 1489 | 1499 | 222 | 187 | 175 |
| CAF27430-1 | Phosphatidate cytidylyltransferase (cdsA1) | 1166.3 | –2.9 | 8.30E–140 | 0.00E + 00 | 0 | 990 | 1069 | 1040 | 157 | 117 | 126 |
| CAF28294-1 | ATP synthase epsilon chain (atpC) | 512.7 | –2.9 | 1.20E–68 | 0.00E + 00 | 0 | 476 | 461 | 419 | 56 | 64 | 62 |
| CAF27381-1 | hypothetical protein | 1709.7 | –2.8 | 2.00E–138 | 0.00E + 00 | 0 | 1511 | 1465 | 1515 | 258 | 180 | 200 |
| CAF28342-1 | Succinate dehydrogenase hydrophobic membrane anchor protein (sdhD) | 1884.7 | –2.8 | 4.50E–121 | 0.00E + 00 | 0 | 1577 | 1789 | 1598 | 285 | 204 | 201 |
| CAF28173-1 | hypothetical protein | 844.7 | –2.8 | 2.00E–110 | 0.00E + 00 | 0 | 746 | 738 | 726 | 111 | 114 | 99 |
| CAF27819-1 | 30S ribosomal protein s11 (rpsK) | 820.7 | –2.8 | 7.20E–104 | 0.00E + 00 | 0 | 688 | 727 | 748 | 115 | 93 | 91 |
| CAF28058-1 | Glycine cleavage system protein t (gcvT) | 1547.7 | –2.7 | 7.50E–168 | 0.00E + 00 | 0 | 1338 | 1360 | 1311 | 225 | 201 | 208 |
| CAF27688-1 | NADH dehydrogenase I, F subunit (nuoF) | 1974.3 | –2.7 | 8.70E–158 | 0.00E + 00 | 0 | 1783 | 1641 | 1717 | 297 | 238 | 247 |
| CAF27411-1 | 50S ribosomal protein l1 (rplA) | 2318.3 | –2.7 | 1.50E–149 | 0.00E + 00 | 0 | 1861 | 2120 | 2033 | 355 | 312 | 274 |
| CAF28169-1 | hypothetical protein | 1802 | –2.7 | 1.00E–126 | 0.00E + 00 | 0 | 1520 | 1606 | 1579 | 282 | 191 | 228 |
| CAF28167-1 | hypothetical protein | 299.7 | –2.6 | 8.80E–29 | 0.00E + 00 | 0 | 239 | 254 | 280 | 52 | 47 | 27 |
qRT-PCR analysis
Since the RNA-seq was performed for the first time on intracellular B. henselae bacteria, numerous steps in both the experimental and analytical processes required optimization. To validate the RNA-seq findings, we employed qRT-PCR on selected random genes. Initially, for cDNA synthesis, RNA samples were considered acceptable only if the CT value was ≥30 using the housekeeping (16S) primers. This ensures that any genomic DNA contamination is minimal. Subsequently, to normalize template DNA for both planktonic bacteria and intracellular bacteria, serial dilutions were performed with the same 16S primers, to produce a CT value between 10 and 15, so that low-expressed genes could be detected. A total of 0.05 ng of cDNA for intracellular bacteria and 0.01 ng of cDNA for planktonic bacteria was used for each sample. The genes that were tested by qRT-PCR are highlighted in Table 3. The downregulated genes were chosen randomly, while the upregulated genes were selected based on previously characterized genes, including an uncharacterized hypothetical gene. There was increased groEL, groES, and trwH1 gene expression in intracellular bacteria compared to expression levels in planktonic bacteria (Fig. 5A and Table S11). Expression of rplJ, ccrM, atpC, and gcvH genes were decreased in intracellular bacteria compared to the level in extracellular B. henselae (Fig. 5A and Table S11). The fold change results of the 7 genes from both qRT-PCR and RNA-seq experiments are presented (Fig. 5B and Table S12), revealing a consistent pattern of expression across the two methodologies.
Fig. 5. Validation of RNA-sequencing data using qRT-PCR.
A qRT-PCR analysis was performed on 7 genes that were either up or downregulated in the intracellular bacteria. Fold change in the gene expression levels between planktonic and intracellular conditions is shown. Data is from three biological replicates with three technical replicates each. B Fold change in the gene expression levels of 7 genes from the RNA-seq data was plotted along with qRT-PCR data.
Functional enrichment analysis of differentially expressed genes
When the up and downregulated genes were uploaded to the STRING database (Table S13), it generated an interaction network that consisted of 79 nodes with 188 edges, with an enrichment p-value 7.36e-06. The network is presented in Fig. 6A. We also observed that two KEGG pathways, oxidative phosphorylation (bhs00190) and ribosome (bhs03010), were enriched with a false discovery rate of 0.0016 and 0.0161, respectively. We have included this subset of protein interactions in Fig. 6B, C. Additionally, STRING had predicted 6 clusters with a false discovery rate <0.05. A noteworthy cluster among these 6 clusters is CL:3089, where four proteins among six were annotated for entry of the bacteria into the host cell. These particular genes are activated in planktonic bacteria and are downregulated more than twofold when B. henselae is in the intracellular environment. While these gene products have not been characterized, their function was predicted by genomic context, computational predictions, and transferred evidence from other organisms. We plotted expression differences within a heatmap (Fig. 6D) and the normalized counts were included in Table 4. In the heatmap visualization, gene expression data is represented by Trimmed Mean of M values (TMM). The heatmap utilizes a 10-color scale, where each color corresponds to a specific range of TMM values evenly distributed across the entire dataset of expression values. Since oxidative phosphorylation and ribosome genes were downregulated in the intracellular environment, we hypothesize that the B. henselae might be growing more slowly compared to the planktonic/extracellular growth conditions. Additionally, B. henselae may be undergoing a metabolic shift to utilize host-derived nutrients more efficiently, leading to the reduction in overall protein synthesis through a change in energy production methods. Our hypothesis is that intracellular bacteria downregulate these genes as a strategy for long-term survival within the host cell, resulting in the entry of the bacteria into a dormant or persistent state where energy and resource utilization are minimized.
Fig. 6. String network of Up and down regulated genes that were significantly changed by ≥2-Fold.
A shows the predicted protein-protein interactions (PPIs) between all the up and down regulated genes that were changed by ≥ 2-Fold. Among these interactions, two KEGG pathways were predicted oxidative phosphorylation and Ribosome. A network of predicted proteins that are involved in the oxidative phosphorylation is presented as a sub network (B) and ribosome in (C). Figure 6D. Heatmap visualization of genes that were downregulated in the intracellular bacteria and organized by function. The trimmed mean of M values (TMM) is denoted by the color scale. The maximum value of the scale is set at 4000 (dark blue), and the minimum is set at 30 (brown). The distribution of the color scale of 10 colors is divided by the total number of data points per range. Downregulated groups in intracellular bacteria compared to planktonic bacteria include genes that are involved in entry into the host, oxidative phosphorylation, and ribosome. All genes shown are statistically significant. The heatmap was generated using Prism V9.4.1.
Table 4.
Normalized read counts of the downregulated genes that were predicted as a network by the STRING database
| Average normalized read counts (TMM) | |||
|---|---|---|---|
| Gene name | in_vitro | intracellular | |
| Entry into host | BH13960 | 764.33 | 146.33 |
| BH13970 | 1349.67 | 309.67 | |
| BH13980 | 377.67 | 86.67 | |
| BH14010 | 3885.67 | 768.33 | |
| Oxidative phosphorylation | cyoC | 1555.00 | 382.33 |
| atpE | 366.67 | 66.00 | |
| nuoK | 136.67 | 31.00 | |
| nuoH | 544.00 | 121.00 | |
| nuoG | 1421.00 | 294.67 | |
| nuoF | 1713.67 | 260.67 | |
| nuoC | 1003.33 | 220.33 | |
| atpC | 452.00 | 60.67 | |
| sdhD | 1654.67 | 230.00 | |
| sdhC | 1213.00 | 212.00 | |
| Ribosome | rpsA | 3427.67 | 838.00 |
| rplK | 968.67 | 195.00 | |
| rplA | 2004.67 | 313.67 | |
| rplJ | 1451.33 | 194.67 | |
| rplL | 780.67 | 71.00 | |
| rplQ | 443.33 | 77.67 | |
| rpsK | 721.00 | 99.67 | |
| rplR | 1015.00 | 130.67 | |
| rpsG | 1621.00 | 418.00 | |
| rplS | 477.67 | 110.00 | |
Discussion
The goal of this study was to compare the transcriptome of B. henselae under intracellular versus extracellular conditions. Quantitative RT-PCR and microarray technologies have provided high-quality data regarding the gene expression of Bartonella under various conditions37, and whole genome sequencing had also been used to study the expression of badA, an outer membrane protein in different strains of B. henselae58. A previous study reported the gene expression profile of B. henselae during human endothelial cell infection using the microarray approach38. In the study presented here, our objectives were to establish a protocol for isolating Bartonella residing within the intracellular environment, to conduct RNA-seq, and to and gain a more comprehensive understanding of the bacterial gene expression profile following invasion of DH82 cells. Using osmotic lysis, we were able to separate bacteria from the cells. We tried multiple methods to separate bacteria from cells, such as using mammalian cell lysis buffer (M-per), 0.1% saponin, and osmotic lysis to disrupt DH82 cells. We tried the filtration method59, to isolate the bacteria from the host cell but overall bacterial counts were low compared to the osmotic lysis (data not shown). This is likely due to the presence of microcolonies60 that were attached to the cells that might not have been filtered through the 5 μm pore-size filter. In our hands, osmotic lysis worked better than other methods, since we were able to separate more viable bacteria comparatively (data not shown). Remarkably, more than 90% of genes were significantly changed in the intracellular DH82 cell environment, suggesting the influence of the host environment in triggering the adaptive responses of bacteria to survive and replicate. Indeed, this is reflected in the notable energy conservations by downregulation of genes associated with Bartonella entry into the host cell.
After overcoming the hurdle of separating bacteria from the cell, we characterized the transcriptome of intracellular B. henselae using an RNA-seq approach. However, after sequencing the RNA from the intracellular Bartonella, more than 90% of reads were mapped to the host. It was shown previously that to reliably identify the differentially expressed genes of bacteria by RNA-seq, 2–3 million reads per sample is considered an optimal sequencing depth61. Since we were able to obtain 3–4 million reads per sample from the intracellular bacteria after the removal of host RNA reads, our experiment generated sufficient reads to describe a reliable transcriptome of the intracellular Bartonella. Previous studies that aimed to separate the bacteria from the host have characterized the transcriptome of bacteria with just 1 million of overall bacterial reads59,62. Taking these numbers into consideration, we could possibly aim to characterize gene expression of B. henselae from smaller populations, which help preserve the bacterial phenotype of intracellular environment. If the challenge of low bacterial read continues to pose an issue in the intracellular system, opting for a dual RNA-seq analysis of both the bacteria and host cell could be an alternative. To get enough reads from the bacteria, the depth coverage has to be around 2-billion reads63.
The type IV secretion system (T4SS) VirB/D4 genes involved in the translocation of Bartonella effector proteins (Beps) into the cytoplasm of the infected endothelial cells64,65, were slightly downregulated in the intracellular bacteria. However, this fold change was not statistically significant. Similarly, BatR that controls the expression of virulence genes during infection38 was slightly downregulated (–0.1-fold) with no significant difference in the expression. The lack of statistical significance suggests that the observed change may not be reliable and could be attributed to the noise in the experimental system. Furthermore, the effector proteins BepB, C, and D were downregulated but had no statistical difference in the expression when compared to the extracellular growth environment, while bepA and E were significantly downregulated by –1 and –0.4-fold, respectively. It is well-established that each Bep protein is involved in modulation of the host cell66–68. During the course of infection, BepD and BepE translocation into the host cell appears to result in the downregulation of the host’s innate immune response. Concurrently, BepG, BepC together with BepF contribute to the induction of internalization of the bacterial aggregates. BepA’s ability to inhibit cell apoptosis indicates a broader impact on host cellular processes66,69. In a host environment, the downregulation of Beps in the intracellular bacteria could be a factor that contributes to persistence. Similarly, BadA (BH01490), which is involved in the adhesion of Bartonella to the host cells22,70 was significantly downregulated. This is in accordance with the previous study that essential virulence factors BadA and VirB/D4 are likely to exhibit differentially expression patterns throughout the infection cycle of Bartonella64. This intricate control of gene expression may ensure Bartonella’s adaptability to vector and mammalian host environments, facilitating optimal interaction with the host cell throughout different stages of transmission and infection.
As facultative intracellular bacteria, Bartonella spp. thrive inside host cells, where they can access essential substrates for growth and replication. By downregulating oxidative phosphorylation, these bacteria minimize their reliance on aerobic respiration, which is particularly advantageous in the often-hypoxic conditions found within host tissues71. This metabolic shift facilitates the utilization of host-derived nutrients, such as amino acids and glucose, enhancing the bacteria’s ability to survive and replicate. For instance, Bartonella species have been shown to sequester heme from the host, which is critical for their metabolic needs and contributes to their virulence72. The ability to adapt their metabolism not only aids nutrient acquisition but also helps Bartonella evade host immune responses by reducing the production of reactive oxygen species (ROS) associated with oxidative phosphorylation, thus minimizing detection by the host immune system73.
Furthermore, Bartonella employs sophisticated mechanisms such as Type IV secretion systems (T4SS) to translocate effector proteins into host cells. These effector proteins modulate host cellular functions, promoting bacterial survival and facilitating nutrient acquisition while simultaneously dampening immune responses74. The interplay between Bartonella metabolism and host cell responses highlights a complex relationship where both parties adapt to each other’s strategies.
Overall, the downregulation of oxidative phosphorylation genes in Bartonella is a clear indication of its evolutionary adaptation to exploit host resources efficiently while surviving within the host environment. This insight underscores the importance of targeting metabolic pathways in developing therapeutic strategies against Bartonella infections.
Previously, it was demonstrated that the alternative sigma factor RpoH1 is essential for the expression of the VirB/D4 T4SS and its secreted effector proteins54. The activation is dependent on RpoH1 that requires the presence of an active BatR/BatS two-component system. RpoH1 levels are in turn modulated by the components of the stringent response (SR), namely DksA and SpoT. BatR expression is controlled by both RpoH1 and the components of SR54. Given the significant downregulation of rpoH1 (–0.7), dksA (–1.1) and spoT (–0.6) expression levels in the intracellular bacteria, we hypothesize that this downregulation could cause the observed decrease in the expression levels of most virulence-associated genes. The inhibition of these virulence genes could be a possible strategy of the Bartonella to combat the host ROS, that are released by the neutrophils and macrophages75.
It is well known that the SR is a regulatory system in bacteria that is triggered by nutrient limitation, amino acid starvation, or other stress conditions. The SR response is mediated by the release of guanosine tetraphosphate (ppGpp) or guanosine pentaphosphate (pppGpp)76,77. This nucleotide signals bacteria to re-allocate cellular resources by inhibiting DNA synthesis, RNA stability, and ribosomal protein synthesis. The (p)ppGpp molecule also promotes upregulation of key regulatory factors for stress resistance, glycolysis, and amino acid synthesis77,78. SpoT is considered as bifunctional synthase/hydrolase that controls the level of the (p)ppGpp79,80 in alphaproteobacteria. When Caulobacter crescentus, an alphaproteobacteria, was analyzed for the adaptive response, the initiation of DNA replication was inhibited by the increasing levels of (p)ppGpp79. Control of the DNA replication is maintained by the two essential regulators of the cell: CtrA and DnaA81,82, where inhibition of DnaA and activation of CtrA inhibits DNA synthesis79. In our study, CtrA was upregulated (0.5) and DnaA was downregulated (–1.3) significantly, which suggests that the levels of (p)ppGpp might be altered and consequently induced the downregulation of genes encoding ribosomal proteins in the intracellular bacteria. However, the levels of (p)ppGpp in the intracellular bacteria need to be evaluated by performing SpoT mutation experiments. In response to stress, Bartonella appears to have increased the synthesis of tRNA as a mechanism to maintain the essential cellular functions, even though overall protein synthesis is reduced. The upregulation of genes encoding tRNA supports the translation process, ensuring the efficacy of the remaining protein synthesis, thus allowing the bacteria to prioritize the synthesis of essential proteins for survival. Subsequently, it can be hypothesized that the increase in the tRNA regulation signals that the bacteria might be preparing for the upregulation of the pathogenic genes, increasing the ability to productively infect the host. Experiments utilizing longer durations of intracellular invasion by the bacteria could offer more insight into the roles of tRNA, SpoT, and (p)ppGpp. It is worth noting that ribosomal synthesis is an energy-intensive process, consuming up to 40% of the cell’s energy83, which possibly explains the downregulation of ribosomal gene expression in intracellular bacteria.
The upregulation of phage-associated genes in intracellular bacteria compared to planktonic bacteria suggests increased phage activity within host cells. Previous studies have shown the presence of bacteriophage-like particles in B. henselae84,85, hinting a potential interaction between phages and the bacteria. Additionally, a decrease in B. henselae growth rate, observed after repeated subcultures has been linked to defective bacteriophages86,87. During the log-phase growth, Bartonella exhibits a low number of phage particles86, resembling the ratio seen during lysogenic phage reversion88. This suggests lysogenic phages may be present, impacting bacterial growth. The increased expression of phage genes in the intracellular environment suggest that the phage genes might be entering the lytic phase, with implications for disease progression. However, further investigation is needed to understand the mechanisms behind this phenomenon, which could provide insights into phage-bacteria interactions and potential therapeutic strategies.
In this study, we infected DH82 cells with B. henselae to model the host intracellular environment, enabling characterization of the infection transcriptome of the bacteria. By using a cell line, Bartonella was not subjected to the host-specific environment that consists of functional macrophages, mature lymphocytes, signaling molecules, complement activation, and host microbiota. The lack of these cells is a limitation of the study because a true host environment can modify the transcriptome of B. henselae during infection. As such, the bacteria do not encounter immune effector mechanisms to eliminate the infection, thereby potentially influencing the activation and repression of specific virulence factors59. Moving forward, we aim to conduct ex vivo and in vivo RNA-seq in susceptible mammalian hosts once we address various technical challenges of working with these intracellular bacteria. Another limitation that must be considered is the bacterial burden. A previous study reported the influence of the multiplicity of infection rates on the overall transcriptional signal63. In a human host, it is highly unlikely that Bartonella grows to high density89. Given the potential impact of cell density on overall gene expression, our future studies will focus on analyzing smaller populations (lower MOIs) of B. henselae to infect the host.
Conclusions
Comparison of the transcriptome of B. henselae between extracellular and intracellular environments offers a window into the ability of this genus of bacteria to host-adapt and survive inside host cells. We previously reported reduced antibiotic susceptibility of Bartonella living within monocytic cells52. Subsequent studies should aim at interrupting survival of Bartonella in all of the microenvironments in which they exist, so it is essential to know the corresponding phenotypes of the bacteria within different cells and tissues. This study will provide a key resource to the Bartonella research field through the availability of comprehensive transcriptomic data on which to support future research.
Methods
Infection and isolation of B. henselae from DH82 cells
The quantity of 2 × 105 DH82 cells were seeded into individual wells of 6-well plate and allowed to adhere to the plate overnight. The next day, 5–7-day old B. henselae cultures grown on blood agar plates were used for infecting the DH82 cells. The B. henselae strain used in this study is San Antonio 2, 267HO04, a human clinical isolate. Initially, bacteria were resuspended in the EMEM + 15% FBS media and dilutions were made. Individual wells of DH82 cells were infected with an MOI of 1:100 to ensure that 100% of the host cells were infected. Six-well plates were then centrifuged at 1200 × g for 10 min. at room temperature (RT). Plates were then incubated at 37 °C + 5%CO2 for 48 h. After 48 h, cells were washed three times with 1X PBS containing calcium and magnesium for 5 min each to remove extracellular bacteria. After the wash, cells were exposed to 500 μl of ice-cold sterile filtered distilled water for 5 min to lyse the cells. A volume of 100 μl of the lysate was plated on blood agar plates for bacterial counting.
The following is the experimental evidence and rationale for the selected isolation procedure. Using the filtration method, after passing the lysate through 25 microns and subsequently through 5 microns, the CFU count was 6 (±5.34) × 103, whereas passing the lysate through only 5-micron filter yielded a CFU of 8(±2.86) × 103. However, using the osmotic lysis method, yielded a CFU of 5.3(±1.6) × 105 of the intracellular bacteria and a CFU of 5.07(±1.73) × 106 for the extracellular bacteria or the cell-exposed bacteria.
When gentamicin (100 µg/ml) antibiotic was used to kill the extracellular bacteria, the assay yielded a CFU count of 1.26 (±0.16) × 105. CFU counts are included in Table S14. The extracellular bacteria were incubated with the antibiotic for 1 h before cells were lysed and plated.
While the gentamicin protection assay was used to kill the extracellular bacteria, it has yielded almost the same number of intracellular bacteria as the osmotic lysis. However, this assay relies on gentamicin to eliminate extracellular bacteria and membrane-bound bacteria, with the assumption that gentamicin cannot penetrate the eukaryotic cells. However, there are previous studies that suspected that higher concentrations of gentamicin for long incubation times possibly kills the intracellular bacteria presumably by internalized gentamicin through pinocytosis90–94. A study has also reported that aminoglycosides slowly penetrate eukaryotic cells and can even reach intracellular concentrations95. This suggests that some gentamicin might enter cells even within 1 h, though likely not bactericidal levels. Even if the intracellular concentration doesn’t reach high enough to kill bacteria, it might be sufficient to cause stress or alter gene expression of the intracellular bacteria. Since a most recent study96 that assessed the bacterial effects of three amino acids in combination with gentamicin, upregulated the metabolites, increased the amino acid abundance, and significantly activated metabolisms. This indicates that even sublethal antibiotic exposure can cause metabolic changes in bacteria. A study has quantitatively shown the internalization of gentamicin and the adverse effects on measuring the invasion potential and enumeration of surviving intracellular bacteria97.
DH82 cell surface staining
To stain the cell membrane of the DH82 cells, MemBrite Fix staining (Biotium, 30093) was used. After removing culture media, cells were washed with 1X PBS buffer and incubated with 1X pre-staining solution for 5 min at 37 °C. After 5 min, pre-staining solution was removed, and 1X MemBrite Fix dye solution was added to cover the cells. Cells were incubated at 4 °C for 30 min. with pre-chilled staining solution to prevent dye internalization. Cells were then rinsed with 1X PBS and were fixed with 4% paraformaldehyde (PFA) in PBS for 20 min at RT.
Immunofluorescence staining
To stain intracellular bacteria, cells were permeabilized with PBS containing 0.1% TritonX-100 for 10 min at RT. Cells were then stained against B. henselae following the previously published protocol52. To stain surface-adhered bacteria, the permeabilization step was omitted and followed by staining against B. henselae.
Imaging was performed using a Nikon Ti2-E motorized fluorescence microscope. Infected and uninfected cells with dye were imaged during the same session with identical acquisition parameters. Fluorescence intensity was optimized on uninfected cells to eliminate the autofluorescence from the cells, and remained constant for all the infected and uninfected cells with the dye.
For differential staining of intracellular and extracellular bacteria, after 48 h, infected DH82 cells were washed and fixed with 4% paraformaldehyde and subsequently incubated with blocking buffer (10% Normal Goat Serum-Gibco, 16-210-072, in PBS) for 1 h. to prevent non-specific binding. After blocking, cells were incubated with the primary antibody: rabbit polyclonal anti–B. henselae (serum derived from a hyperimmunized rabbit eight weeks after inoculation with in vitro propagated B. henselae) at a dilution of 1:300 for 1 h followed by three washes using wash buffer (1X PBS, 0.2% fish skin gelatin). Cells were then incubated with the secondary antibody Goat Anti-rabbit IgG-Alexa Fluor 594 (Thermo Fisher Scientific, R37117) diluted 1:1000 in blocking buffer. After secondary antibody incubation, cells were washed with wash buffer and were permeabilized using 0.1% Triton X-100 in 1X PBS for 20 min. Cells were then incubated with blocking buffer for 1 h and incubated with the primary antibody: rabbit polyclonal anti–B. henselae and counterstained with secondary antibody Goat Anti-rabbit IgG-Alexa Fluor 488 (Thermo Fisher Scientific, A11034) diluted 1:1000 in blocking buffer. Slides were washed and cells were counterstained with DAPI for 10 min to stain nuclei (EMD millipore, 2160), then mounted with the anti-quenching solution (Thermofisher, P36934) and coverslipped.
Imaging was performed using a Nikon Ti2-E motorized fluorescence microscope using a 40X objective and three fluorescence channels (DAPI, FITC, and TRITC) were used to capture an image field. A total of at least 50 images were taken from each individual experiment and yellow dots (extracellular bacteria) were counted manually from each field. The counts from the individual fields were shown (Table S1) and the representative images are shown in (Supplementary Fig. 3)
This experiment was repeated by staining with secondary antibody Goat Anti-rabbit IgG-Alexa Fluor 488 first and then with Goat Anti-rabbit IgG-Alexa Fluor 594. Switching the order of secondary antibodies provided a way to validate specificity and enhance the reliability of our immunofluorescence results. This experiment was repeated two times with secondary antibody combinations. The average percentage of extracellular bacteria from four independent experiments was 12.795%.
RNAscope (RNA in-situ Hybridization)
RNAscope is commercially available from Advanced Cell Diagnostics, Inc. (ACDBio). RNAscope was performed according to the manufacturer’s guidelines from RNAscope Multiplex Fluorescent Detection Kit version 2 (MK-50 010 and 323100).
DH82 cells that were infected with B. henselae for 48 h were fixed with 4% PFA at RT for 30 min. After removing PFA, cells were gently rinsed twice with 1X PBS and ~5 drops of RNAscope Hydrogen Peroxide was added to cover the cells followed by incubation at RT for 10 min. Slides were then washed with distilled water. After washing slides with distilled water, excess liquid was removed by tapping the slide, and 2–4 drops of 1:15 diluted protease III was added, then incubated for 10 min at RT in a humidity control tray. Slides were washed with 1X PBS and probed for B. henselae using 23S rRNA (ACDBio, 23S rRNA transcript, 485621-C3). A positive control probe was used to target the PPIB gene (ACDBio, 437441) of DH82 cells. As a negative control, a probe targeting the dapB gene (ACDBio, 320871) of B. subtilis was used. After addition of probes, slides were incubated in the EZ hybridization oven (ACDBio, 321710) using a humidity control tray (ACDBio, 310012) and slide rack (ACDBio, 310017) for 2 h. After probe hybridization, amplification and detection steps were performed. Amplifier 1 was initially incubated on slides for 30 min at 40 °C and washed with wash buffer three times each for 2 min. Slides were then incubated with Amplifier 2 for 30 min as before, washed, and incubated with a final layer of amplifier, Amplifier 3, and incubated for 15 min at 40 °C and washed as before. For the development of the signal, HRP (horseradish peroxidase)-C1 was added to the slide to target the probes (PPIB and dapB) assigned to channel C1 and HRP-C3 was added to target the probe (23S rRNA against B. henselae) and incubated in the hybridization oven for 15 min at 40 °C. Finally, slides were incubated with fluorescent molecules from PerkinElmer [Tyramide Signal Amplification (TSA) plus Cyanine 3 system: NEL744001KT or TSA plus Cyanine 5 system: NEL745001KT]. These fluorescent molecules bind to the cascade of signal amplification molecules resulting in signal detection. Imaging was performed using a Nikon Ti2-E motorized fluorescence microscope as mentioned above.
RNA extraction and purification from both lab cultured bacteria and host cell adapted bacteria
Intracellular bacteria. Immediately after osmotic lysis, 1 ml of bacterial RNA protect reagent (Qiagen, 76104) was added and incubated for 15 min at RT. After 15 min, the resulting lysate was pelleted at high speed 14,000 rpm for 15 min. Supernatant was removed and the pellet was resuspended in 1X PBS and pelleted again at high speed. The resulting supernatant was removed. To the pellet containing bacteria, a mixture of lysozyme (15 mg/ml) containing proteinase K prepared in 1X TE buffer was added and incubated for 15 min by vortexing for every 2–3 min. After incubation with lysozyme, RLT buffer from Qiagen was added for complete lysis of bacteria. The lysed bacteria were purified by following manufacturer’s protocol of Qiagen RNA mini kit. Bacteria cultured on blood agar plates. Bacteria were suspended in EMEM media +15% FBS and pelleted. After pelleting, media was removed, and bacteria were treated as above and RNA was isolated.
Enrichment of bacterial RNA
Using MICROBEnrich kit
To eliminate most of the host ribosomal RNA and mRNA from the RNA purified from the host-adapted bacteria, the MICROBEnrich™ kit (Thermofisher, AM1901) was adopted and the manufacturer’s protocol was followed. Briefly, a total of 8.5 µg of the host-adapted bacteria total RNA mixture was used per sample. To the RNA mixture, binding buffer and capture oligo mix was added, which captures and removes 18S rRNA, 28S rRNA, and polyadenylated mRNAs of host RNA. This mixture was then heat denatured at 70 °C. Later, the mixture was incubated at 37 °C, which allows the capture oligonucleotides to hybridize to homologous regions of the 18S and 28S rRNAs. Next, Oligo MagBeads were employed to selectively remove the capture oligonucleotides from the reaction mixture. The resulting supernatant after Oligo MagBeads removal contains the enriched bacterial RNA. After enrichment, equal amounts of RNA from pre- and post-enrichment steps were run on a 2100 Bioanalyzer (Agilent Technologies) using Agilent RNA 6000 Nano chip. The MICROBEnrich™ kit does not remove 5S rRNA of the host.
Ribosomal depletion of the enriched bacterial total RNA
To remove the host and bacterial rRNA, RiboCop rRNA Depletion kits for Human/Mouse/Rat (Lexogen, 144) and for bacteria (Lexogen, 126) were simultaneously used. Manufacturer’s user guides 144UG288 and 125UG246 were followed. Briefly, a total of 500 ng of total RNA from the bacteria control samples and 1000 ng of bacterial-enriched RNA from the mixture sample was utilized. A combined probe mix from the above-mentioned kits was added to the RNA and samples were denatured at 75 °C for 5 min. In this step, only control samples were denatured because in the MICROBEnrich step, enriched RNA samples were already denatured. From the next step, all the samples, both enriched and control bacterial RNA were treated according to the protocol. After denaturation, all the samples were subjected to a temperature of 65 °C for 30 min on a thermomixer with agitation at 1250 rpm. This step helps to hybridize the probes to the target sequences of the rRNA. Later, depletion beads were used to remove probes that were hybridized to rRNA from the solution. The final purified product that is supposed to be free from rRNAs was used for the Next-Generation Sequencing (NGS) library preparation.
Total RNA-sequencing Library preparation
RNA libraries were prepared following Lexogen’s user manual of CORALL Total RNA-Seq Library Prep Kit (Lexogen, 095). This library preparation kit is fragmentation-free, which provides complete transcript coverage including start and end sites. It seamlessly integrates Unique Molecular Identifiers (UMIs) while maintaining protocol-inherent strand specificity (>99%).
Briefly, rRNA-depleted RNA was used as the starting material. The library generation started by random hybridization of displacement stop primers (DSP) to the RNA template. These primers contain partial Illumina-compatible sequences at the 5′ ends. Reverse transcription extends each DSP to the next DSP where transcription is effectively stopped. This random priming of the DSP to DSP determines the insert size of the library. In the next step, a highly efficient ligation of linker oligos to the 3′ ends of first strand cDNA fragments introduces UMIs and partial Illumina-compatible P5 sequences. This primary library is purified using magnetic beads to remove ligation reaction components. Since the mRNA content affects the number of PCR cycles needed for the final library amplification, a qPCR assay was utilized to optimize the number of cycles that are required for each sample for endpoint PCR. This step normalizes the total amount of input across all the samples. This step will also prevent both under- and over-cycling, the latter of which may bias sequencing results. After determining the number of cycles required for the endpoint PCR, the library was amplified to add the complete adaptor sequences required for cluster generation and to produce sufficient material for quality control and sequencing. The i7 indices were added during this step in order to uniquely multiplex the samples for the sequencing run. The resulting libraries were then purified using magnetic beads to get rid of PCR components, which could interfere with quantification and sequencing on an Illumina NGS instrument. Finally, the library samples were quality controlled (QC’d) on a bioanalyzer and quantified. The libraries were sequenced on an Illumina NextSeq 500 using the 75 bp single-end protocol at the Genomics core, University of Birmingham, Alabama. A total of 55–70 million single end reads were generated per sample.
Bioinformatic analysis
For the initial analysis of the RNA-seq data, Lexogen’s BlueBee pipeline was used. Briefly, UMI sequences were trimmed and added to the read identifiers. Next, cutadapt was used to remove artifacts and trim adapter sequences from the sequencing reads. These trimmed reads were quality checked using FastQC. Reads were then aligned to the Bacterial (B. henselae) genome using STAR aligner. UMI tools were used to remove reads with identical mapping coordinates and UMI sequences were collapsed to remove PCR duplicates in addition to only keeping mapped reads in Binary Alignment Map (BAM) files. Mix2 then was used to compile transcript and gene abundance estimates. The read counts were then normalized and differentially expressed genes were estimated using DeSeq2.
For down sampling of the raw reads, the Seqtk tool98 (https://github.com/lh3/seqtk) with the command “sample” was used. Using Seqtk, we performed two rounds (3 million and 4.5 million) of downsampling. The downsampled reads were then quality checked using FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Since the sequences contains UMI sequences, we performed UMI extraction using UMI-tools99. The extracted reads were processed using the tool Cutadapt100 to find and remove adapter sequences. Along with the adapter trimming, Cutadapt was also used to remove low quality bases below the cutoff value of 30. These trimmed reads were then aligned to the reference genome (https://ftp.ensemblgenomes.ebi.ac.uk/pub/bacteria/release-57/fasta/bacteria_0_collection/bartonella_henselae_str_houston_1_gca_000046705/) using BWA-MEM101. UMI tools were used to remove PCR duplicates as mentioned above. Read counts for each gene were determined using featureCounts102. We used B. henselae gff3 file from ensembl (https://ftp.ensemblgenomes.ebi.ac.uk/pub/bacteria/release-57/gff3/bacteria_0_collection/bartonella_henselae_str_houston_1_gca_000046705/). Differential expression analysis and visualization was performed using the R package edgeR103. An overview of the analysis is presented as Fig. 3. Genes were considered to be significantly differentially expressed when the relative expression had a fold change (FC) ≥2.0 and a P value of ≤0.05, unless otherwise mentioned. The computer setup for the analysis of the RNA-seq and scripts for the edgeR were from “RNA-Seq by Example” volume of the Biostar Handbook ISBN: 978-0-578-80435-4(https://www.biostarhandbook.com/books/rnaseq/index.html). To generate a PCA plot, the ClustVis webtool104 was used.
STRING database analysis
Enrichment of the genes that were up or downregulated by twofold or more was performed using STRING105. The genes were uploaded onto the database and the interactions between the genes were predicted. The analysis pipeline was set to have a cut-off interaction confidence score ≥0.4 and the predicted cluster would have cutoff of p < 0.05 corrected for multiple testing within each category using the Benjamin–Hochberg procedure.
qRT-PCR
Validation of the expression profiles of selected genes was performed by real-time quantitative RT-PCR (qRT-PCR) on total RNA samples prepared from both intracellular and in vitro grown/extracellular bacteria. First-strand cDNA was synthesized using the High-Capacity RNA-to-cDNA kit (Thermofisher#4387406) from 500 ng of total RNA as per manufacturer’s instructions. Each qPCR reaction was performed in a total volume of 10 µL with 2X PowerUp SYBR Green I Master Mix (Thermofisher#A25742). A non-template control and a reverse transcriptase negative reaction was included with every round of qPCR. A total of three technical replicate reactions were run per gene target per sample. Reactions were run using the Applied Biosystems QuantStudio 6 Flex Real-Time PCR instrument under fast cycling mode for 40 cycles. Primers were designed using Primer3web V4.1.0106–108. To check for specificity, melt curve analysis as well as subsequent agarose gel electrophoresis was performed on each normalized to the 16S reference gene using the 2-(∆∆Ct) method109, and sequence-specific primers used for qPCR are listed in (Table S15). The average of 2-(∆∆Ct) values from three biological replicate experiments was calculated and the graph was plotted. Standard error of mean was calculated based on the variability of the 2-(∆∆Ct) value of three biological replicates.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Acknowledgements
The authors would like to thank Drs. Timothy Haystead and David Alcorta for their collaboration on Bartonella and for subject matter expertise.
Abbreviations
- CSD
cat scratch disease
- ECM
extracellular matrix
- RNA
ribonucleic acid
- RNAseq
RNA sequencing
- PCR
polymerase chain reaction
- qPCR
quantitative PCR
- rRNA
ribosomal RNA
- T4SS
Type IV secretion systems
- DAPI
4’,6-diamidino-2-phenylindole
- PCA
principal component analysis
- TMM
trimmed mean of M values
- EMEM
Eagle’s minimal essential media
- MOI
multiplicity of infection
- PBS
phosphate buffered saline
- UMIs
unique molecular identifiers
Author contributions
S.K.G.G. and M.E.E. conceptualized the project; S.K.G.G., M.E.E., and J.R.C. established the methodology; S.K.G.G. and JRC performed validation; S.K.G.G., J.R.C., R.G.M., and M.E.E. formally analyzed the data; S.K.G.G. and R.G.M. engaged in the investigation; M.E.E. and E.B.B. provided the resources; S.K.G.G. provided data curation and original draft preparation; All authors contributed to review and editing; M.E.E. oversaw project administration; M.E.E. and E.B.B. were responsible for funding acquisition. All authors read and approved the final manuscript.
Peer review
Peer review information
Communications Biology thanks Burt Anderson and Karthika Rajeeve [name] for their contribution to the peer review of this work. Primary Handling Editor: Tobias Goris.
Funding
This research was funded by the Steven and Alexandra Cohen Foundation and NIH base grant P51 OD011104-61; RRID: SCR_008167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Data availability
The datasets generated and/or analysed during the current study are available in the NCBI repository (https://submit.ncbi.nlm.nih.gov/subs/sra/SUB14175801/overview) with locator information file accession numbers BioSample accessions: SAMN40140122, SAMN40140123, SAMN40140124, SAMN40140125, SAMN40140126, SAMN40140127, SAMN40140128, SAMN40140129, SAMN40140130. Object IDs and corresponding URLs: 40140122, 40140123, 40140124, 40140125, 40140126, 40140127, 40140128, 40140129, 40140130.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
The online version contains supplementary material available at 10.1038/s42003-025-07535-9.
References
- 1.Alsmark, C. M. et al. The louse-borne human pathogen Bartonella quintana is a genomic derivative of the zoonotic agent Bartonella henselae. Proc. Natl Acad. Sci. USA101, 9716–9721 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Koehler, J. E. Bartonella infections. Adv. Pediatr. Infect. Dis.11, 1–27 (1996). [PubMed] [Google Scholar]
- 3.Tu, N. et al. A family of genus‐specific RNAs in tandem with DNA‐binding proteins control expression of the badA major virulence factor gene in Bartonella henselae. MicrobiologyOpen6, e00420 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Drummond, M. R. et al. Bartonella henselae endocarditis in an elderly patient. PLoS Negl. Trop. Dis.14, e0008376 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ericson, M. E. et al. Bartonella henselae detected in malignant melanoma, a preliminary study. Pathogens10, 326 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Guo, S., Pottanat, N. D., Herrmann, J. L. & Schamberger, M. S. Bartonella endocarditis and diffuse crescentic proliferative glomerulonephritis with a full-house pattern of immune complex deposition. BMC Nephrol.23, 181 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Koehler, J. E. et al. Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N. Engl. J. Med.337, 1876–1883 (1997). [DOI] [PubMed] [Google Scholar]
- 8.Lashnits, E. et al. Schizophrenia and Bartonella spp. Infection: a pilot case-control study. Vector Borne Zoonotic Dis.21, 413–421 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dai, Y. N. et al. Peliosis hepatis: 2 case reports of a rare liver disorder and its differential diagnosis. Med. (Baltim.).96, e6471 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Okaro, U., Addisu, A., Casanas, B. & Anderson, B. Bartonella Species, an emerging cause of blood-culture-negative endocarditis. Clin. Microbiol. Rev.30, 709–746 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Rising, T., Fulton, N. & Vasavada, P. Splenorenal manifestations of Bartonella henselae infection in a pediatric patient. Case Rep. Radiol.2016, 7803832 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Samarkos M., Antoniadou V., Vaiopoulos A. G., Psichogiou M. Encephalopathy in an adult with cat-scratch disease. BMJ Case Rep. 2018, bcr-2017–223647 (2018). [DOI] [PMC free article] [PubMed]
- 13.Sendi, P. et al. Bartonella-associated transverse myelitis. Emerg. Infect. Dis.23, 712–713 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Wu, A. M. et al. Serology negative bartonella neuroretinitis in an immunocompromised patient. Retin Cases Brief. Rep.16, 36–39 (2022). [DOI] [PubMed] [Google Scholar]
- 15.Henn, J. B. et al. Seroprevalence of antibodies against Bartonella species and evaluation of risk factors and clinical signs associated with seropositivity in dogs. Am. J. Vet. Res.66, 688–694 (2005). [DOI] [PubMed] [Google Scholar]
- 16.Kyme, P. A. et al. Unusual trafficking pattern of Bartonella henselae -containing vacuoles in macrophages and endothelial cells. Cell. Microbiol.7, 1019–1034 (2005). [DOI] [PubMed] [Google Scholar]
- 17.Dehio, C., Meyer, M., Berger, J., Schwarz, H. & Lanz, C. Interaction of Bartonella henselae with endothelial cells results in bacterial aggregation on the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate by a unique structure, the invasome. J. Cell Sci.110, 2141–2154 (1997). [DOI] [PubMed] [Google Scholar]
- 18.Solano-Gallego, L., Bradley, J., Hegarty, B., Sigmon, B. & Breitschwerdt, E. Bartonella henselae IgG antibodies are prevalent in dogs from southeastern USA. Vet. Res.35, 585–595 (2004). [DOI] [PubMed] [Google Scholar]
- 19.Schülein, R. et al. Invasion and persistent intracellular colonization of erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella. J. Exp. Med.193, 1077–1086 (2001). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Yager, J. A. et al. Bacillary angiomatosis in an immunosuppressed dog. Vet. Dermatol.21, 420–428 (2010). [DOI] [PubMed] [Google Scholar]
- 21.Kirby, J. E. & Nekorchuk, D. M. Bartonella-associated endothelial proliferation depends on inhibition of apoptosis. Proc. Natl Acad. Sci. USA99, 4656–4661 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Riess, T. et al. Bartonella adhesin A mediates a proangiogenic host cell response. J. Exp. Med.200, 1267–1278 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kaiser, P. O. et al. The head of Bartonella adhesin A is crucial for host cell interaction of Bartonella henselae. Cell Microbiol.10, 2223–2234 (2008). [DOI] [PubMed] [Google Scholar]
- 24.Müller, N. F. et al. Trimeric autotransporter adhesin-dependent adherence of Bartonella henselae, Bartonella quintana, and Yersinia enterocolitica to matrix components and endothelial cells under static and dynamic flow conditions. Infect. Immun.79, 2544–2553 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Thibau, A. et al. Adhesion of Bartonella henselae to fibronectin is mediated via repetitive motifs present in the stalk of bartonella adhesin A. Microbiol Spectr.10, e0211722 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vaca, D. J. et al. Adhesion of human pathogenic bacteria to endothelial cells is facilitated by fibronectin interaction. Microbes Infect.25, 105172 (2023). [DOI] [PubMed] [Google Scholar]
- 27.Batut, J., Andersson, S. G. E. & O’Callaghan, D. The evolution of chronic infection strategies in the α-proteobacteria. Nat. Rev. Microbiol.2, 933–945 (2004). [DOI] [PubMed] [Google Scholar]
- 28.Pulliainen, A. T. et al. Bacterial effector binds host cell adenylyl cyclase to potentiate Gαs-dependent cAMP production. Proc. Natl Acad. Sci.109, 9581–9586 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Jin X. et al. Advancements in understanding the molecular and immune mechanisms of Bartonella pathogenicity. Front. Microbiol. 14 (2023). https://www.frontiersin.org/articles/10.3389/fmicb.2023.1196700 [DOI] [PMC free article] [PubMed]
- 30.Resto-Ruiz, S. I. et al. Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection. Infect. Immun.70, 4564–4570 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Hadfield, T. L., Malaty, R. H., Van Dellen, A., Wear, D. J. & Margileth, A. M. Electron microscopy of the bacillus causing cat-scratch disease. J. Infect. Dis.152, 643–645 (1985). [DOI] [PubMed] [Google Scholar]
- 32.Margileth, A. W. et al. Cat-scratch disease. Bacteria in skin at the primary inoculation site. JAMA252, 928–931 (1984). Aug 17. [DOI] [PubMed] [Google Scholar]
- 33.Osborne, B. M., Butler, J. J. & Mackay, B. Ultrastructural observations in cat scratch disease. Am. J. Clin. Pathol.87, 739–744 (1987). [DOI] [PubMed] [Google Scholar]
- 34.Guccion, J. G., Gibert, C. L., Ortega, L. G. & Hadfield, T. L. Cat scratch disease and acquired immunodeficiency disease: diagnosis by transmission electron microscopy. Ultrastruct. Pathol.20, 195–202 (1996). [DOI] [PubMed] [Google Scholar]
- 35.Dehio, C. Molecular and cellular basis of bartonella pathogenesis. Annu Rev. Microbiol.58, 365–390 (2004). [DOI] [PubMed] [Google Scholar]
- 36.Abromaitis, S. & Koehler, J. E. The Bartonella quintana extracytoplasmic function sigma factor RpoE has a role in bacterial adaptation to the arthropod vector environment. J. Bacteriol.195, 2662–2674 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Abromaitis, S. et al. Bartonella quintana deploys host and vector temperature-specific transcriptomes. PLoS ONE8, e58773 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Quebatte, M. et al. The BatR/BatS two-component regulatory system controls the adaptive response of Bartonella henselae during human endothelial cell infection. J. Bacteriol.192, 3352–3367 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sarshar, M. et al. A simple, fast and reliable scan-based technique as a novel approach to quantify intracellular bacteria. BMC Microbiol.19, 252 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Dehio, C. Bartonella interactions with endothelial cells and erythrocytes. Trends Microbiol.9, 279–285 (2001). [DOI] [PubMed] [Google Scholar]
- 41.Wellman, M. L., Krakowka, S., Jacobs, R. M. & Kociba, G. J. A macrophage-monocyte cell line from a dog with malignant histiocytosis. Vitr. Cell Dev. Biol.24, 223–229 (1988). [DOI] [PubMed] [Google Scholar]
- 42.Heinrich, F. et al. Passage-dependent morphological and phenotypical changes of a canine histiocytic sarcoma cell line (DH82 cells). Vet. Immunol. Immunopathol.163, 86–92 (2015). [DOI] [PubMed] [Google Scholar]
- 43.Gauthier, D. T. et al. Characterization of a novel transitional group Rickettsia species (Rickettsia tillamookensis sp. nov.) from the western black-legged tick, Ixodes pacificus. Int J. Syst. Evol. Microbiol.71, 004880 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Lin, M. et al. Comparative analysis of genome of Ehrlichia sp. HF, a model bacterium to study fatal human ehrlichiosis. BMC Genomics22, 11 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Bin Park, W. et al. Gene expression of toll-like receptors, cytokines and a nuclear factor and cytokine secretion in DH82 canine macrophage cells infected with Brucella canis. Vet. Immunol. Immunopathol.260, 110607 (2023). [DOI] [PubMed] [Google Scholar]
- 46.Soto, J. M., Mas, A., Rodrigo, J. A., Alieva, T. & Domínguez-Bernal, G. Label-free bioanalysis of Leishmania infantum using refractive index tomography with partially coherent illumination. J. Biophotonics12, e201900030 (2019). [DOI] [PubMed] [Google Scholar]
- 47.Moura de Aguiar, D. et al. Isolation and characterization of a novel pathogenic strain of Ehrlichia minasensis. Microorganisms7, 528 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Bekebrede, H., Lin, M., Teymournejad, O. & Rikihisa, Y. Discovery of in vivo virulence genes of obligatory intracellular bacteria by random mutagenesis. Front Cell Infect. Microbiol.10, 2 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Oteo, J. A. et al. Prevalence of Bartonella spp. by culture, PCR and serology, in veterinary personnel from Spain. Parasit. Vectors10, 553 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Lashnits, E., Correa, M., Hegarty, B. C., Birkenheuer, A. & Breitschwerdt, E. B. Bartonella seroepidemiology in dogs from North America, 2008–2014. J. Vet. Intern. Med.32, 222–231 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Breitschwerdt, E. B. et al. Bartonella vinsonii subsp. berkhoffii and Bartonella henselae bacteremia in a father and daughter with neurological disease. Parasites Vectors3, 29 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Gadila, S. K. G. & Embers, M. E. Antibiotic susceptibility of Bartonella grown in different culture conditions. Pathogens10, 718 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Battisti, J. M., Sappington, K. N., Smitherman, L. S., Parrow, N. L. & Minnick, M. F. Environmental signals generate a differential and coordinated expression of the heme receptor gene family of Bartonella quintana. Infect. Immun.74, 3251–3261 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Québatte, M., Dick, M. S., Kaever, V., Schmidt, A. & Dehio, C. Dual input control: activation of the Bartonella henselae VirB/D4 type IV secretion system by the stringent sigma factor RpoH1 and the BatR/BatS two-component system. Mol. Microbiol.90, 756–775 (2013). [DOI] [PubMed] [Google Scholar]
- 55.Franz, B. & Kempf, V. A. Adhesion and host cell modulation: critical pathogenicity determinants of Bartonella henselae. Parasites Vectors4, 54 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Tsukamoto, K. et al. The Bartonella autotransporter BafA activates the host VEGF pathway to drive angiogenesis. Nat. Commun.11, 3571 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Deng, H. et al. Strategies of exploitation of mammalian reservoirs by Bartonella species. Vet. Res.43, 15 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Thibau, A. et al. Long-read sequencing reveals genetic adaptation of Bartonella adhesin A among different Bartonella henselae Isolates. Front Microbiol.13, 838267 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Wong, T. Y. et al. Analysis of the In Vivo Transcriptome of Bordetella pertussis during Infection of Mice. mSphere4, e00154-19 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Eicher, S. C. & Dehio, C. Bartonella entry mechanisms into mammalian host cells. Cell. Microbiol.14, 1166–1173 (2012). [DOI] [PubMed] [Google Scholar]
- 61.Haas, B. J., Chin, M., Nusbaum, C., Birren, B. W. & Livny, J. How deep is deep enough for RNA-Seq profiling of bacterial transcriptomes? BMC Genomics.13, 734 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Nuss, A. M. et al. Tissue dual RNA-seq allows fast discovery of infection-specific functions and riboregulators shaping host-pathogen transcriptomes. Proc. Natl Acad. Sci. USA114, E791–E800 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Hayward, R. J., Humphrys, M. S., Huston, W. M. & Myers, G. S. A. Dual RNA-seq analysis of in vitro infection multiplicity and RNA depletion methods in Chlamydia-infected epithelial cells. Sci. Rep.11, 10399 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Lu, Y. Y. et al. Bartonella henselae trimeric autotransporter adhesin BadA expression interferes with effector translocation by the VirB/D4 type IV secretion system. Cell. Microbiol.15, 759–778 (2013). [DOI] [PubMed] [Google Scholar]
- 65.Schulein, R. et al. A bipartite signal mediates the transfer of type IV secretion substrates of Bartonella henselae into human cells. Proc. Natl Acad. Sci. USA102, 856–861 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Fromm K., Dehio C. The impact of Bartonella VirB/VirD4 Type IV secretion system effectors on eukaryotic host cells. Front. Microbiol. 12 (2021). Available from: https://www.frontiersin.org/articles/10.3389/fmicb.2021.762582 [DOI] [PMC free article] [PubMed]
- 67.Molloy, S. Bartonella gets under the skin. Nat. Rev. Microbiol.12, 529–529 (2014). [DOI] [PubMed] [Google Scholar]
- 68.Siamer, S. & Dehio, C. New insights into the role of Bartonella effector proteins in pathogenesis. Curr. Opin. Microbiol.23, 80–85 (2015). [DOI] [PubMed] [Google Scholar]
- 69.Harms, A. et al. Evolutionary dynamics of pathoadaptation revealed by three independent acquisitions of the VirB/D4 Type IV secretion system in Bartonella. Genome Biol. Evol.9, 761–776 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Linke, D., Riess, T., Autenrieth, I. B., Lupas, A. & Kempf, V. A. J. Trimeric autotransporter adhesins: variable structure, common function. Trends Microbiol.14, 264–270 (2006). [DOI] [PubMed] [Google Scholar]
- 71.Fuchs, T. M., Eisenreich, W., Heesemann, J. & Goebel, W. Metabolic adaptation of human pathogenic and related nonpathogenic bacteria to extra- and intracellular habitats. FEMS Microbiol. Rev.36, 435–462 (2012). [DOI] [PubMed] [Google Scholar]
- 72.Harms, A. & Dehio, C. Intruders below the radar: molecular pathogenesis of Bartonella spp. Clin. Microbiol. Rev.25, 42 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Eisenreich W., Heesemann J., Rudel T., Goebel W. Metabolic host responses to infection by intracellular bacterial pathogens. Front. Cell Infect. Microbiol.3 (2013) https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2013.00024/full. [DOI] [PMC free article] [PubMed]
- 74.Wagner, A. & Dehio, C. Role of distinct type-IV-secretion systems and secreted effector sets in host adaptation by pathogenic Bartonella species. Cell Microbiol.21, e13004 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P. & Malik, A. B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal.20, 1126–1167 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Dalebroux, Z. D., Svensson, S. L., Gaynor, E. C. & Swanson, M. S. ppGpp conjures bacterial virulence. Microbiol. Mol. Biol. Rev.74, 171–199 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Liu, J. et al. Comparative transcriptomic analysis of global gene expression mediated by (p) ppGpp reveals common regulatory networks in Pseudomonas syringae. BMC Genomics.21, 296 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Dalebroux, Z. D. & Swanson, M. S. ppGpp: magic beyond RNA polymerase. Nat. Rev. Microbiol.10, 203–212 (2012). [DOI] [PubMed] [Google Scholar]
- 79.Lesley, J. A. & Shapiro, L. SpoT regulates DnaA stability and initiation of DNA replication in carbon-starved Caulobacter crescentus. J. Bacteriol.190, 6867–6880 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Irving, S. E., Choudhury, N. R. & Corrigan, R. M. The stringent response and physiological roles of (pp)pGpp in bacteria. Nat. Rev. Microbiol.19, 256–271 (2021). [DOI] [PubMed] [Google Scholar]
- 81.Gorbatyuk, B. & Marczynski, G. T. Physiological consequences of blocked Caulobacter crescentus dnaA expression, an essential DNA replication gene. Mol. Microbiol.40, 485–497 (2001). [DOI] [PubMed] [Google Scholar]
- 82.Quon, K. C., Yang, B., Domian, I. J., Shapiro, L. & Marczynski, G. T. Negative control of bacterial DNA replication by a cell cycle regulatory protein that binds at the chromosome origin. Proc. Natl Acad. Sci.95, 120–125 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Maguire, B. A. Inhibition of bacterial ribosome assembly: a suitable drug target? Microbiol Mol. Biol. Rev.73, 22–35 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Anderson, B., Goldsmith, C., Johnson, A., Padmalayam, I. & Baumstark, B. Bacteriophage-like particle of Rochalimaea henselae. Mol. Microbiol.13, 67–73 (1994). [DOI] [PubMed] [Google Scholar]
- 85.Anderson, B. et al. Analysis of 36-kilodalton protein (PapA) associated with the bacteriophage particle of Bartonella henselae. DNA Cell Biol.16, 1223–1229 (1997). [DOI] [PubMed] [Google Scholar]
- 86.Maggi, R. G. & Breitschwerdt, E. B. Isolation of bacteriophages from Bartonella vinsonii subsp. berkhoffii and the characterization of Pap31 gene sequences from bacterial and phage DNA. J. Mol. Microbiol Biotechnol.9, 44–51 (2005). [DOI] [PubMed] [Google Scholar]
- 87.Maggi, R. G., Duncan, A. W. & Breitschwerdt, E. B. Novel chemically modified liquid medium that will support the growth of seven Bartonella species. J. Clin. Microbiol.43, 2651–2655 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Birge E. A. Bacterial and Bacteriophage Genetics (New York, NY: Springer, 2000). https://link.springer.com/10.1007/978-1-4757-3258-0
- 89.Balakrishnan, N. et al. Experimental infection of dogs with Bartonella henselae and Bartonella vinsonii subsp. berkhoffii. Vet. Immunol. Immunopathol.156, 153–158 (2013). [DOI] [PubMed] [Google Scholar]
- 90.90. Sokolovska A., Becker C. E. & Stuart L. M. Measurement of phagocytosis, phagosome acidification, and intracellular killing of Staphylococcus aureus. Curr. Protoc. Immunol. Chapter 14, 14.30.1–14.30.12 (2012). [DOI] [PubMed]
- 91.Drevets, D. A., Canono, B. P., Leenen, P. J. & Campbell, P. A. Gentamicin kills intracellular Listeria monocytogenes. Infect. Immun.62, 2222–2228 (1994). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Menashe, O., Kaganskaya, E., Baasov, T. & Yaron, S. Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow. Antimicrob. Agents Chemother.52, 920–926 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Flannagan, R. S., Heit, B. & Heinrichs, D. E. Intracellular replication of Staphylococcus aureus in mature phagolysosomes in macrophages precedes host cell death, and bacterial escape and dissemination. Cell Microbiol.18, 514–535 (2016). [DOI] [PubMed] [Google Scholar]
- 94.Pratten, M. K. & Lloyd, J. B. Pinocytosis and phagocytosis: the effect of size of a particulate substrate on its mode of capture by rat peritoneal macrophages cultured in vitro. Biochim Biophys. Acta881, 307–313 (1986). [DOI] [PubMed] [Google Scholar]
- 95.VanCleave, T. T., Pulsifer, A. R., Connor, M. G., Warawa, J. M. & Lawrenz, M. B. Impact of gentamicin concentration and exposure time on intracellular Yersinia pestis. Front. Cell Infect. Microbiol.7, 505 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Guo, J. et al. Effect of three different amino acids plus gentamicin against methicillin-resistant Staphylococcus aureus. Infect. Drug Resist.16, 4741–4754 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Kim, J. H., Chaurasia, A. K., Batool, N., Ko, K. S. & Kim, K. K. Alternative enzyme protection assay to overcome the drawbacks of the gentamicin protection assay for measuring entry and intracellular survival of Staphylococci. Infect. Immun.87, e00119-19 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Robinson, D. G. & Storey, J. D. subSeq: determining appropriate sequencing depth through efficient read subsampling. Bioinformatics30, 3424–3426 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res.27, 491–499 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J.17, 10–12 (2011). [Google Scholar]
- 101.Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics25, 1754–1760 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics30, 923–930 (2014). [DOI] [PubMed] [Google Scholar]
- 103.Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics26, 139–140 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Metsalu, T. & Vilo, J. ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap. Nucleic Acids Res.43, W566–W570 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Szklarczyk, D. et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res.47, D607–D613 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Kõressaar, T. et al. Primer3_masker: integrating masking of template sequence with primer design software. Bioinformatics34, 1937–1938 (2018). [DOI] [PubMed] [Google Scholar]
- 107.Untergasser, A. et al. Primer3—new capabilities and interfaces. Nucleic Acids Res.40, e115 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Koressaar, T. & Remm, M. Enhancements and modifications of primer design program Primer3. Bioinformatics23, 1289–1291 (2007). [DOI] [PubMed] [Google Scholar]
- 109.Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods25, 402–408 (2001). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets generated and/or analysed during the current study are available in the NCBI repository (https://submit.ncbi.nlm.nih.gov/subs/sra/SUB14175801/overview) with locator information file accession numbers BioSample accessions: SAMN40140122, SAMN40140123, SAMN40140124, SAMN40140125, SAMN40140126, SAMN40140127, SAMN40140128, SAMN40140129, SAMN40140130. Object IDs and corresponding URLs: 40140122, 40140123, 40140124, 40140125, 40140126, 40140127, 40140128, 40140129, 40140130.






